低风险HEART Pathway患者中负荷试验的低收益
该研究分析了一家学术医院2017年1月至2018年7月的胸痛登记数据,纳入HEAR评分≤3且肌钙蛋白不升高的低风险HEART Pathway患者共2074例(占全部4743次评估的43.7%)。其中仅4.1%(84/2074)接受了负荷试验,8.3%(7/84)结果不确定,2.6%(2/84)为阳性;2例阳性中1例冠脉广泛通畅、另1例为多支梗阻性冠心病,负荷试验诊断收益为1.2%(1/84)。HEAR评分每增加1分(aOR 2.17,95%CI 1.45-3.24)和男性(aOR 1.59,95%CI 1.02-2.49)与接受负荷试验相关。作者结论为低风险HEART Pathway患者中负荷试验不常见、收益低,且更常见于男性和HEAR评分较高者。
要点
- 低风险HEART Pathway患者(HEAR评分≤3且肌钙蛋白不升高)中仅4.1%(84/2074)接受了负荷试验。
- 84例接受负荷试验的低风险患者中,2.6%(2/84)为阳性,8.3%(7/84)结果不确定。
- 2例阳性负荷试验中仅1例造影证实多支梗阻性冠心病,负荷试验诊断收益为1.2%(1/84)。
- HEAR评分每增加1分与接受负荷试验相关(aOR 2.17,95%CI 1.45-3.24),男性亦与接受负荷试验相关(aOR 1.59,95%CI 1.02-2.49)。
- 低风险HEART Pathway患者中负荷试验不常见、收益低,且更常见于男性和HEAR评分较高者。
适用人群与场景
- 低风险HEART Pathway患者:HEAR评分≤3且肌钙蛋白不升高,来自一家学术医院的胸痛登记数据(2017年1月至2018年7月)。
诊断标准与关键阈值
- 低风险HEART Pathway定义为HEAR评分≤3且肌钙蛋白不升高。
研究设计与关键结果
- 研究类型为对一家学术医院胸痛登记数据的分析;共4743次HEART Pathway评估,其中43.7%(2074/4743)为低风险。
- 低风险患者中4.1%(84/2074)接受了负荷试验;84例中8.3%(7/84)结果不确定,2.6%(2/84)为阳性。
- 2例阳性负荷试验中,造影显示1例冠脉广泛通畅、另1例为多支梗阻性冠心病,负荷试验诊断收益为1.2%(1/84)。
- HEAR评分每增加1分与接受负荷试验相关(aOR 2.17,95%CI 1.45-3.24);男性与接受负荷试验相关(aOR 1.59,95%CI 1.02-2.49)。
证据类型、等级与局限
- 证据类型:基于单家学术医院胸痛登记数据的分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论:低风险HEART Pathway患者中负荷试验不常见、收益低,且更常见于男性和HEAR评分较高者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The HEART Pathway identifies low-risk chest pain patients for discharge from the Emergency Department without stress testing. However, HEART Pathway recommendations are not always followed. The objective of this study is to determine the frequency and diagnostic yield of stress testing among low-risk patients.
METHODS: An academic hospital's chest pain registry was analyzed for low-risk HEART Pathway patients (HEAR score ≤ 3 with non-elevated troponins) from 1/2017 to 7/2018. Stress tests were reviewed for inducible ischemia. Diagnostic yield was defined as the rate of obstructive CAD among patients with positive stress testing. T-test or Fisher's exact test was used to test the univariate association of age, sex, race/ethnicity, and HEAR score with stress testing. Multivariate logistic regression was used to determine the association of age, sex, race/ethnicity, and HEAR score with stress testing.
RESULTS: There were 4743 HEART Pathway assessments, with 43.7% (2074/4743) being low-risk. Stress testing was performed on 4.1% (84/2074). Of the 84 low-risk patients who underwent testing, 8.3% (7/84) had non-diagnostic studies and 2.6% (2/84) had positive studies. Among the 2 patients with positive studies, angiography revealed that 1 had widely patent coronary arteries and the other had multivessel obstructive coronary artery disease, making the diagnostic yield of stress testing 1.2% (1/84). Each one-point increase in HEAR score (aOR 2.17, 95% CI 1.45-3.24) and being male (aOR 1.59, 95% CI 1.02-2.49) were associated with testing.
CONCLUSIONS: Stress testing among low-risk HEART Pathway patients was uncommon, low yield, and more likely in males and those with a higher HEAR score.
参考来源
- Ashburn NP, Smith ZP, Hunter KJ, et al. The disutility of stress testing in low-risk HEART Pathway patients. Am J Emerg Med. 2020. PMID: 33041122. doi:10.1016/j.ajem.2020.08.032
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。